Differential regulation of apoptosis in normal versus transformed mammary epithelium by lutein and retinoic acid

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 3, 2000, Pages 257-263

  Sumantran, Venil N ^a   Zhang, Rong ^a   Lee, David S ^a   Wicha, Max S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; PROTEIN BAX; PROTEIN BCL 2; RETINOIC ACID; XANTHOPHYLL;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CELL GROWTH; CELL PROTECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CHEMOPREVENTION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; LUTEIN; SIMIAN VIRUS 40; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0034075818     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gerster, H. Anticarcinogenic effect of common carotenoids. Int. J. Vitam. Nutr. Res., 63: 93-121, 1993.
2. Krinsky, N. I. Effects of carotenoids in cellular and animal systems. Am. J. Nutr., 53: 2385-2465, 1991.
3. Freudenheim, J. L., Marshall, J. R., Vena, J. E, and Laughlin, R. Premenopausal breast cancer risk and intake of fruits, vegetables and related nutrients. J. Natl. Cancer Inst., 88: 340-348, 1996.
4. Van Poppel, G. Carotenoids and cancer: an update with emphasis on human intervention studies. Eur. J. Cancer, 29A: 1335-1344, 1993.
5. Lotan, R. Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J. Natl. Cancer Inst., 87: 1655-1657, 1995.
6. Muindi, J. R. F. Retinoids in clinical cancer therapy. Cancer Treat. Res., 87: 305-342, 1996.
7. Liu, Y., Lee, M. O., Wang, H. G., Li, Y., and Zhang, X. K. Retinoic acid receptor β mediates the growth-inhibitory effects of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell. Biol., 16: 1138-1149, 1996.
8. Krupitza, G., Hulla, W., Harant, H., Grunt, T., and Dittrich, C. Retinoic acid induced death of ovarian carcinoma cells correlates with c-myc stimulation. Int. J. Cancer, 61: 649-657, 1995.
9. Goodwin, T. W. Metabolism, nutrition and function of carotenoids. Annu. Rev. Nutr., 6: 273-297, 1986.
10. Rauscher, R., Edenharder, R., and Platt, K. L. In vitro antimutagenic and anticlastogenic effects of carotenoids and solvent extracts from fruits and vegetables rich in carotenoids. Mutat. Res., 413: 129-142, 1998.
11. Zhang, L. X., Cooney, R. V., and Bertram, J. S. Carotenoids enhance gap junctional communications and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis (Lond.), 12: 2109-114, 1991.
12. Rock, C. L., Kusluski, R. A., Galvez, M. M., and Ethier, S. P. Carotenoids induce morphological changes in human mammary epithelial cell cultures. Nutr. Cancer, 23: 319-333, 1995.
13. Rock, C. L. Carotenoids. Biology and treatment. Pharmacol. Ther., 75: 185-197, 1997.
14. Chew, B. P., Wong, M. W., and Wong, T. S. Effects of lutein from marigold extract on immunity and growth of mammary tumors in mice. Anticancer Res., 16: 3689-3694, 1996.
15. Kim, H., Araki, S., Kim, D. J., and Park, C. B. Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis (Lond.), 19: 81-85, 1998.
16. Rock, C. L., Saxe, G. A., Ruffin, M. T., August, D. A., and Schottenfeld, D. Carotenoids, vitamin A, and estrogen receptor status in breast cancer. Nutr. Cancer, 25: 281-296, 1996.
17. Ludlow, J. W. Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. FASEB J., 7: 866-871, 1993.
18. Monaghan, P., Robertson, D., Amos, T. A., Dyer, M. J., Mason, D. V., and Greaves, M. F. Ultrastructural localization of Bcl-2 protein. Cytochemistry, 40: 1819-1825, 1992.
19. Prince, M. R., and Frisoli, J. K. Beta-carotene accumulation in serum and skin. Am. J. Clin. Nutr., 57: 175-181, 1993.
20. Potischman, N., McCulloch, C. E., and Byers, T. Breast cancer and dietary and plasma concentration of carotenoids and vitamin A. Am. J. Clin. Nutr., 52: 909-915, 1990.
21. Kao, C. Y., Nomata, K., Oakley, C. S., Welsch, C. W., and Chang, C. C. Two types of normal human breast epithelial cells derived from reduction mammoplasty: phenotypic characterization and response to SV40 transfection. Carcinogenesis (Lond.)., 16: 531-538, 1995.
22. Tewari, M., and Dixit, V. M. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem., 270: 3255-3259, 1995.
23. Sumantran, V. N., Ealovega, M. W., Nunez, G., Clarke, M. F., and Wicha, M. S. Overexpression of bcl-xS sensitizes MCF-7 cells to chemotherapy induced apoptosis. Cancer Res., 55: 2507-2510, 1995.
24. Carpentier, Y., Mayer, P., Bobichon, H., and Desoize, B. Cofactors in in vitro induction of apoptosis by all-trans retinoic acid. Biochem. Pharmacol., 55: 177-184, 1998.
25. 1 arrest but not apoptosis of normal human mammary epithelial cells. Cell Growth Differ., 8: 631-641, 1997.
26. Reed, J. C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol., 7: 541-546, 1995.
27. Yang, E., and Korsemeyer, S. J. Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood, 88: 386-401, 1996.
28. Schwartz, J., and Sklar, G. Selective cytotoxic effect of carotenoids and α-tocopherol on human cancer cell lines in vitro. J. Oral Maxillofac. Surg., 50: 367-373, 1992.
29. Elder, D. J., Hague, A., Hicks, D. J., and Paraskeva, C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro transformed adenoma relative to adenoma cell lines. Cancer Res., 56: 2273-2276, 1996.
30. Shiff, S. J., Qiao, L., and Tsai, L. Sulindac sulfide, an aspirin-like compound inhibits proliferation causes cell cycle quiescence and induces apoptosis in HT-29 colon adenocarcinoma cells J. Clin. Investig., 96: 491-503, 1995.
31. Oridate, N., Lotan, D., Mitchell, M. F., Hong, W. K., and Lotan, R. Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implications for chemoprevention. J. Cell. Biochem. Suppl., 23: 80-86, 1995.
32. Zhang, K. Z., Westberg, J. A., Holtta, E., and Andersson, L. Bcl-2 regulates neural differentiation. Proc. Natl. Acad. Sci. USA, 93: 4504-4508, 1996.
33. Lasorella, I., Iavarone, A., and Israel, M. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance. Cancer Res., 55: 4711-4716, 1995.
34. Gudas, L. J. Retinoids, retinoid-responsive genes, cell differentiation, and cancer. Cell Growth Differ., 3: 655-662, 1992.
35. Silvestrini, S., Veneroni, S., Daidone, M. G., Benini, E., and Borscchi, P. The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer in patients. J. Natl. Cancer Inst., 86: 499-504, 1994.
36. Naik, P., Karrim, J., and Hanahan, D. The rise and fall of apoptosis during multi-stage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev., 10: 2105-2116, 1996.
37. Olopade, O. I., Adeyanju, M. O., Safa, A. R., Hagos, F., Mick, R., Thompson, C. B., and Recant, W. M. Overexpression of Bcl-x in primary breast cancer is associated with high tumor grade and metastases. Cancer J. Sci. Am., 3: 230-237, 1997.
38. Miyashita, T., and Reed, J. C. Bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res., 52: 5407-5411, 1995.
39. Minn, A. J., Rudin, C. M., Boise, L. H., and Thompson, C. B. Expression of Bcl-xL can confer a multidrug resistance phenotype. Blood, 86: 1903-1910, 1995.